VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details) - Warrants [Member]	3 Months Ended
Stock-Based Compensation (Details) - Warrants [Member]	Mar. 31, 2023 $ / shares shares
Number of warrants Outstanding beginning balance \| shares	539,000
Number of warrants Expired/Cancelled \| shares	(125,000)
Number of warrants outstanding ending balance \| shares	414,000
Number of Warrants Exercisable \| shares	360,000
Weighted Average Exercise Price Outstanding balance \| $ / shares	$ 3.80
Weighted Exercise Price Expired/Cancelled \| $ / shares	2.47
Weighted Average Exercise Price ending balance \| $ / shares	4.20
Weighted Average Exercise Price exercisable \| $ / shares	$ 4.37